ask="3.08"
ask_size="12000"
average_daily_volume="4128870"
bid="3.04"
bid_size="100"
book_value="-1.75"
change="-0.03"
change_from_200_day_moving_average="-1.97"
change_from_50_day_moving_average="-0.73"
change_from_52_week_high="-5.97"
change_From_52_week_low="0.22"
change_in_percent="-0.97%"
close="3.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="122599000"
high="3.10"
high_52_weeks="9.02"
last_trade_date="2/2/2017"
last_trade_price="3.05"
last_trade_size="103754"
last_trade_time="4:00pm"
low="3.02"
low_52_weeks="2.83"
market_capitalization="395.33M"
moving_average_200_day="5.02"
moving_average_50_day="3.78"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.07"
pe_ratio="N/A"
peg_ratio="-0.48"
percent_change_from_200_day_moving_average="-39.27%"
percent_change_from_50_day_moving_average="-19.34%"
percent_change_from_52_week_high="-66.17%"
percent_change_from_52_week_low="+7.77%"
previous_close="3.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.82"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="5.39"
stock_exchange="NGM"
symbol="MACK"
volume="1369433"
weeks_range_52="2.83 - 9.02"
